Thiogenesis Therapeutics Corp (TTI.CA) Stock Earnings & Estimates
Canada - TSX Venture Exchange - TSX-V:TTI -
0.55 CAD
-0.01 (-1.79%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A 346.91% | N/A 273.92% | N/A 94.41% | N/A 65.00% | N/A 37.36% | |||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A 587.50% | N/A 258.86% | N/A 411.52% | N/A 106.54% | N/A 71.79% | N/A 40.14% | |
| EBIT YoY % growth | -2.009M | -5.206M -159.13% | -3.579M 31.25% | N/A -134.15% | N/A 587.50% | N/A 258.86% | N/A 411.52% | N/A 106.54% | N/A 71.79% | N/A 40.14% | ||
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A -9.12% | N/A 574.77% | N/A 255.10% | N/A 412.43% | N/A 106.50% | N/A 71.89% | N/A 40.15% |
All data in CAD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CAD
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | N/A | N/A |